Fujiwara H, Hamaoka T
Biomedical Research Center, Osaka University Medical School, Japan.
Immunol Res. 1995;14(4):271-91. doi: 10.1007/BF02935625.
Tumor-bearing hosts develop antitumor immune responses. However, a number of immunosuppressive mechanisms come into operation with the progression of tumor growth. This article will review the observations regarding the modulation of antitumor immune responses in the tumor-bearing state, and consider the mechanisms underlying tumor-induced immune defects, especially in the light of the induction of an abnormal cytokine network. We will also describe the restoration of suppressed antitumor immune responses by administration of a particular cytokine, interleukin-12.
荷瘤宿主会产生抗肿瘤免疫反应。然而,随着肿瘤生长的进展,多种免疫抑制机制开始起作用。本文将综述关于荷瘤状态下抗肿瘤免疫反应调节的观察结果,并探讨肿瘤诱导免疫缺陷的潜在机制,特别是鉴于异常细胞因子网络的诱导。我们还将描述通过给予特定细胞因子白细胞介素-12来恢复受抑制的抗肿瘤免疫反应。